![]()

![]()
What is GSK doing to respond to society's healthcare needs?
> Contribution to global health
What is GSK doing to improve access to medicines in developing countries?
How do you make patient safety a priority?
What is GSK's commitment to ethical sales and marketing?
What is GSK doing to address climate change?
How do you support disadvantaged communities?
Welcome to GlaxoSmithKline's (GSK's) Corporate Responsibility (CR) Review 2007. In this document we summarise our approach to some of the key social, ethical and environmental issues associated with our business. We highlight the progress we made in 2007, some of the challenges we face and answer some of the questions frequently asked by our stakeholders. This Review does not provide a complete account of corporate responsibility at GSK. There is more information in our full CR Report.
Back to top 2007 highlights
![]()
£3.3bn
1.1bn
268m
£282m
Community investment valued at £282m
![]()
45%
22%
This section contains information in several formats:
To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.